Compare WPP & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WPP | TMDX |
|---|---|---|
| Founded | 1985 | 1998 |
| Country | United Kingdom | United States |
| Employees | 104000 | N/A |
| Industry | Advertising | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.6B |
| IPO Year | N/A | 2019 |
| Metric | WPP | TMDX |
|---|---|---|
| Price | $15.05 | $113.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 9 |
| Target Price | N/A | ★ $154.00 |
| AVG Volume (30 Days) | 608.8K | ★ 880.3K |
| Earning Date | 02-26-2026 | 05-07-2026 |
| Dividend Yield | ★ 13.98% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 4.87 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | N/A | $24.12 |
| Revenue Next Year | $2.48 | $18.69 |
| P/E Ratio | $38.96 | ★ $23.34 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $14.81 | $62.42 |
| 52 Week High | $40.95 | $156.00 |
| Indicator | WPP | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 30.73 | 33.27 |
| Support Level | N/A | $106.27 |
| Resistance Level | $19.55 | $131.86 |
| Average True Range (ATR) | 0.55 | 7.08 |
| MACD | -0.13 | -2.50 |
| Stochastic Oscillator | 7.98 | 8.26 |
Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe. WPP is the largest media buying entity in the world.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.